Nayak Sanjay, Chief Strategy Officer at Ocular Therapeutix, Inc. ($OCUL), made five open market sales of company shares over the last year, totaling about $167 thousand. His most recent sale occurred on February 23, 2026. These OCUL insider sales rank 8,798th out of 11,678 individual insiders, well below the average sale amount of $8.6 million across 6.4 transactions per insider. Nayak Sanjay recorded no open market purchases in the past 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1759 | $8.28 | 330,653.0000 | 187,241,483 | 0.53% | 0.00% |
| Feb. 12, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 10348 | $9.04 | 332,412.0000 | 187,241,483 | 3.02% | 0.01% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | A | Stock Option (Right to Buy) | 197650 | $0.00 | 197,650.0000 | 187,241,483 | 9999.99% | 0.11% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | A | Common Stock | 64900 | $0.00 | 342,760.0000 | 187,241,483 | 23.36% | 0.03% |
| Nov. 24, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1878 | $12.04 | 277,860.0000 | 183,919,808 | 0.67% | 0.00% |
| Aug. 25, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1885 | $12.04 | 279,738.0000 | 172,594,662 | 0.67% | 0.00% |
| May 23, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1862 | $7.17 | 281,623.0000 | 169,396,989 | 0.66% | 0.00% |
| Feb. 24, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1895 | $6.84 | 283,485.0000 | 158,265,162 | 0.66% | 0.00% |
| Feb. 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | A | Stock Option (Right to Buy) | 334000 | $0.00 | 334,000.0000 | 158,265,162 | 9999.99% | 0.21% |
| Feb. 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | A | Common Stock | 111000 | $0.00 | 285,380.0000 | 158,265,162 | 63.65% | 0.07% |
| Nov. 25, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1814 | $9.00 | 174,380.0000 | 166,992,735 | 1.03% | 0.00% |
| Aug. 23, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 1832 | $9.02 | 176,194.0000 | 165,824,778 | 1.03% | 0.00% |
| May 23, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | S | Common Stock | 2274 | $5.84 | 178,026.0000 | 132,021,945 | 1.26% | 0.00% |
| Feb. 22, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | A | Common Stock | 80300 | $0.00 | 180,300.0000 | 85,596,594 | 80.30% | 0.09% |
| Feb. 22, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Nayak Sanjay | Chief Strategy Officer | A | Stock Option (Right to Buy) | 244550 | $0.00 | 244,550.0000 | 85,596,594 | 9999.99% | 0.29% |